Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry

Journal of Proteome Research

Volumn 11, Issue 3, 2012, Pages 1749-1758

  Wehr, Angela Y ^a   Hwang, Wei Ting ^b   Blair, Ian A ^a   Yu, Kenneth H ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

immunoaffinity depletion; LC?MS MS; serum biomarkers; SILAC; SILAP; tryptic digestion

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN M; GELATINASE A; PLASMA PROTEIN; PROTEOME; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 7; STABLE ISOTOPE; TRYPSIN; UNCLASSIFIED DRUG; VILLIN 2;

ANTIBODY AFFINITY; CONFERENCE PAPER; CONTROLLED STUDY; DILUTION; HUMAN; HUMAN CELL; ISOTOPE DILUTION ASSAY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; BLOOD PROTEINS; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; HUMANS; ISOTOPE LABELING; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; PROTEOLYSIS; REFERENCE STANDARDS; TANDEM MASS SPECTROMETRY; TRYPSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84857816089     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr201011f     Document Type: Conference Paper

References (49)

1. Piersma, S. R.; Fiedler, U.; Span, S.; Lingnau, A.; Pham, T. V.; Hoffmann, S.; Kubbutat, M. H.; Jimenez, C. R. Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: Method evaluation, differential analysis, and verification in serum J. Proteome. Res. 2010, 9 (4) 1913-1922
2. Hood, B. L.; Malehorn, D. E.; Conrads, T. P.; Bigbee, W. L. Serum proteomics using mass spectrometry Methods Mol. Biol. 2009, 520, 107-128
3. Yu, K. H.; Barry, C. G.; Austin, D.; Busch, C. M.; Sangar, V.; Rustgi, A. K.; Blair, I. A. Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery J. Proteome. Res. 2009, 8 (3) 1565-1576
4. Crnogorac-Jurcevic, T.; Gangeswaran, R.; Bhakta, V.; Capurso, G.; Lattimore, S.; Akada, M.; Sunamura, M.; Prime, W.; Campbell, F.; Brentnall, T. A.; Costello, E.; Neoptolemos, J.; Lemoine, N. R. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma Gastroenterology 2005, 129 (5) 1454-1463
5. Chen, R.; Yi, E. C.; Donohoe, S.; Pan, S.; Eng, J.; Cooke, K.; Crispin, D. A.; Lane, Z.; Goodlett, D. R.; Bronner, M. P.; Aebersold, R.; Brentnall, T. A. Pancreatic cancer proteome: The proteins that underlie invasion, metastasis, and immunologic escape Gastroenterology 2005, 129 (4) 1187-1197
6. Gronborg, M.; Kristiansen, T. Z.; Iwahori, A.; Chang, R.; Reddy, R.; Sato, N.; Molina, H.; Jensen, O. N.; Hruban, R. H.; Goggins, M. G.; Maitra, A.; Pandey, A. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach Mol. Cell. Proteomics. 2006, 5 (1) 157-171
7. Yu, K. H.; Rustgi, A. K.; Blair, I. A. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry J. Proteome. Res. 2005, 4 (5) 1742-1751
8. Ono, M.; Shitashige, M.; Honda, K.; Isobe, T.; Kuwabara, H.; Matsuzuki, H.; Hirohashi, S.; Yamada, T. Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectrometry Mol. Cell. Proteomics. 2006, 5 (7) 1338-1347
9. Kim, K.; Visintin, I.; Alvero, A. B.; Mor, G. Development and validation of a protein-based signature for the detection of ovarian cancer Clin. Lab. Med. 2009, 29 (1) 47-55
10. Jackson, D.; Craven, R. A.; Hutson, R. C.; Graze, I.; Lueth, P.; Tonge, R. P.; Hartley, J. L.; Nickson, J. A.; Rayner, S. J.; Johnston, C.; Dieplinger, B.; Hubalek, M.; Wilkinson, N.; Perren, T. J.; Kehoe, S.; Hall, G. D.; Daxenbichler, G.; Dieplinger, H.; Selby, P. J.; Banks, R. E. Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer Clin. Cancer Res. 2007, 13 (24) 7370-7379
11. Matsubara, J.; Honda, K.; Ono, M.; Tanaka, Y.; Kobayashi, M.; Jung, G.; Yanagisawa, K.; Sakuma, T.; Nakamori, S.; Sata, N.; Nagai, H.; Ioka, T.; Okusaka, T.; Kosuge, T.; Tsuchida, A.; Shimahara, M.; Yasunami, Y.; Chiba, T.; Hirohashi, S.; Yamada, T. Reduced plasma level of CXC chemokine ligand 7 in patients with pancreatic cancer Cancer Epidemiol., Biomarkers Prev. 2011, 20 (1) 160-171
12. Pan, S.; Chen, R.; Crispin, D. A.; May, D.; Stevens, T.; McIntosh, M. W.; Bronner, M. P.; Ziogas, A.; Anton-Culver, H.; Brentnall, T. A. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling J. Proteome. Res. 2011, 10 (5) 2359-2376
13. Xu, R. N.; Fan, L.; Rieser, M. J.; El-Shourbagy, T. A. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS J. Pharm. Biomed. Anal. 2007, 44 (2) 342-355
14. Jemal, M.; Xia, Y. Q. LC-MS development strategies for quantitative bioanalysis Curr. Drug Metab. 2006, 7 (5) 491-502
15. Wickremsinhe, E. R.; Singh, G.; Ackermann, B. L.; Gillespie, T. A.; Chaudhary, A. K. A review of nanoelectrospray ionization applications for drug metabolism and pharmacokinetics Curr. Drug Metab. 2006, 7 (8) 913-928
16. Ciccimaro, E.; Blair, I. A. Stable-isotope dilution LC-MS for quantitative biomarker analysis Bioanalysis 2010, 2 (2) 311-341
17. Rangiah, K.; Tippornwong, M.; Sangar, V.; Austin, D.; Tetreault, M. P.; Rustgi, A. K.; Blair, I. A.; Yu, K. H. Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancer J. Proteome. Res. 2009, 8 (11) 5153-5164
18. Anderson, N. L.; Anderson, N. G. The human plasma proteome: History, character, and diagnostic prospects Mol. Cell. Proteomics. 2002, 1 (11) 845-867
19. Tirumalai, R. S.; Chan, K. C.; Prieto, D. A.; Issaq, H. J.; Conrads, T. P.; Veenstra, T. D. Characterization of the low molecular weight human serum proteome Mol. Cell. Proteomics. 2003, 2 (10) 1096-1103
20. Gong, Y.; Li, X.; Yang, B.; Ying, W.; Li, D.; Zhang, Y.; Dai, S.; Cai, Y.; Wang, J.; He, F.; Qian, X. Different immunoaffinity fractionation strategies to characterize the human plasma proteome J. Proteome. Res. 2006, 5 (6) 1379-1387
21. Bjorhall, K.; Miliotis, T.; Davidsson, P. Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples Proteomics 2005, 5 (1) 307-317
22. Polaskova, V.; Kapur, A.; Khan, A.; Molloy, M. P.; Baker, M. S. High-abundance protein depletion: Comparison of methods for human plasma biomarker discovery Electrophoresis 2010, 31 (3) 471-482
23. Anderson, N. L.; Anderson, N. G.; Haines, L. R.; Hardie, D. B.; Olafson, R. W.; Pearson, T. W. Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA) J. Proteome Res. 2004, 3 (2) 235-244
24. Diamandis, E. P. Cancer biomarkers: Can we turn recent failures into success? J. Natl. Cancer Inst. 2010, 102 (19) 1462-1467
25. Yocum, A. K.; Yu, K.; Oe, T.; Blair, I. A. Effect of immunoaffinity depletion of human serum during proteomic investigations J. Proteome. Res. 2005, 4 (5) 1722-1731
26. Kuzyk, M. A.; Smith, D.; Yang, J.; Cross, T. J.; Jackson, A. M.; Hardie, D. B.; Anderson, N. L.; Borchers, C. H. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma Mol. Cell. Proteomics. 2009, 8 (8) 1860-1877
27. Yan, Y.; Weaver, V. M.; Blair, I. A. Analysis of protein expression during oxidative stress in breast epithelial cells using a stable isotope labeled proteome internal standard J. Proteome Res. 2005, 4 (6) 2007-2014
28. Ong, S. E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D. B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics Mol. Cell. Proteomics 2002, 1 (5) 376-386
29. Ong, S. E.; Mann, M. A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC) Nat. Protoc. 2006, 1 (6) 2650-2660
30. Jesnowski, R.; Furst, D.; Ringel, J.; Chen, Y.; Schrodel, A.; Kleeff, J.; Kolb, A.; Schareck, W. D.; Lohr, M. Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis: Deactivation is induced by matrigel and N -acetylcysteine Lab. Invest. 2005, 85 (10) 1276-1291
31. Maclean, B.; Tomazela, D. M.; Abbatiello, S. E.; Zhang, S.; Whiteaker, J. R.; Paulovich, A. G.; Carr, S. A.; Maccoss, M. J. Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry Anal. Chem. 2010, 82 (24) 10116-10124
32. Maclean, B.; Tomazela, D. M.; Shulman, N.; Chambers, M.; Finney, G. L.; Frewen, B.; Kern, R.; Tabb, D. L.; Liebler, D. C.; Maccoss, M. J. Skyline: An open source document editor for creating and analyzing targeted proteomics experiments Bioinformatics 2010, 26 (7) 966-968
33. Wehr, A. Y.; Furth, E. E.; Sangar, V.; Blair, I. A.; Yu, K. H. Analysis of the human pancreatic stellate cell secreted proteome Pancreas 2011, 40 (4) 557-566
34. Viswanathan, C. T.; Bansal, S.; Booth, B.; DeStefano, A. J.; Rose, M. J.; Sailstad, J.; Shah, V. P.; Skelly, J. P.; Swann, P. G.; Weiner, R. Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays Pharm. Res. 2007, 24 (10) 1962-1973
35. Bansal, S.; DeStefano, A. Key elements of bioanalytical method validation for small molecules AAPS. J. 2007, 9 (1) E109-E114
36. Gerber, S. A.; Rush, J.; Stemman, O.; Kirschner, M. W.; Gygi, S. P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS Proc. Natl. Acad. Sci. U. S. A 2003, 100 (12) 6940-6945
37. Barr, J. R.; Maggio, V. L.; Patterson, D. G., Jr.; Cooper, G. R.; Henderson, L. O.; Turner, W. E.; Smith, S. J.; Hannon, W. H.; Needham, L. L.; Sampson, E. J. Isotope dilution-mass spectrometric quantification of specific proteins: Model application with apolipoprotein A-I Clin. Chem. 1996, 42 (10) 1676-1682
38. Brun, V.; Dupuis, A.; Adrait, A.; Marcellin, M.; Thomas, D.; Court, M.; Vandenesch, F.; Garin, J. Isotope-labeled protein standards: toward absolute quantitative proteomics Mol. Cell. Proteomics. 2007, 6 (12) 2139-2149
39. Roche, S.; Tiers, L.; Provansal, M.; Seveno, M.; Piva, M. T.; Jouin, P.; Lehmann, S. Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: The more the better? J. Proteomics 2009, 72 (6) 945-951
40. Tu, C.; Rudnick, P. A.; Martinez, M. Y.; Cheek, K. L.; Stein, S. E.; Slebos, R. J.; Liebler, D. C. Depletion of abundant plasma proteins and limitations of plasma proteomics J. Proteome. Res. 2010, 9 (10) 4982-4991
41. Ciccimaro, E.; Hanks, S. K.; Yu, K. H.; Blair, I. A. Absolute quantification of phosphorylation on the kinase activation loop of cellular focal adhesion kinase by stable isotope dilution liquid chromatography/mass spectrometry Anal. Chem. 2009, 81 (9) 3304-3313
42. Ciccimaro, E.; Hanks, S. K.; Blair, I. A. Quantification of focal adhesion kinase activation loop phosphorylation as a biomarker of Src activity Mol. Pharmacol. 2009, 75 (3) 658-666
43. Agger, S. A.; Marney, L. C.; Hoofnagle, A. N. Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid chromatography-multiple- reaction-monitoring mass spectrometry Clin. Chem. 2010, 56 (12) 1804-1813
44. Pulukuri, S.; Gorantia, B.; Knost, J.; Rao, J. Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer Oncogene 2009, 28 (31) 2829-2838
45. Sotiropoulou, G.; Anisowicz, A.; Sager, R. Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer J. Biol. Chem. 1997, 272 (2) 903-910
46. Qiu, J.; Ramachandran, C.; Yao, B.; Gopalakrishnan, S.; Fields, C.; Delmas, A.; Dyer, L.; Melnick, S.; Yachnis, A.; Schwatrz, P.; Fine, H.; Brown, K.; Robertson, K. Invasion suppressor cystatin E/M (CST6): High-level cell type-specific expression in normal brain and epigenetic silencing in gliomas Lab. Invest. 2008, 88 (9) 910-925
47. Vizioli, M. G.; Sensi, M.; Miranda, C.; Cleris, L.; Formelli, F.; Anania, M. C.; Pierotti, M. A.; Greco, A. IGFBP7: An oncosuppressor gene in thyroid carcinogenesis Oncogene 2010, 29 (26) 3835-3844
48. Chen, Y.; Cui, T.; Knosel, T.; Yang, L.; Zoller, K.; Petersen, I. IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation Lung Cancer 2011, 73 (1) 38-44
49. Cui, Y.; Li, T.; Zhang, D.; Han, J. Expression of Ezrin and phosphorylated Ezrin (pEzrin) in pancreatic ductal adenocarcinoma Cancer Invest. 2010, 28 (3) 242-247